Literature DB >> 25012669

Preoperative prognostic value of MRI findings in 108 patients with idiopathic normal pressure hydrocephalus.

J Virhammar1, K Laurell2, K G Cesarini3, E-M Larsson4.   

Abstract

BACKGROUND AND
PURPOSE: MR imaging is used in the diagnostic evaluation of patients with idiopathic normal pressure hydrocephalus. The aim of this study was to describe the prevalence of several imaging features and their prognostic use in the selection of shunt candidates with idiopathic normal pressure hydrocephalus.
MATERIALS AND METHODS: Preoperative MR imaging scans of the brain were retrospectively evaluated in 108 patients with idiopathic normal pressure hydrocephalus who had undergone a standardized, clinical evaluation before and 12 months after shunt surgery. The MR imaging features investigated were the Evans index, callosal angle, narrow sulci at the high convexity, dilation of the Sylvian fissure, diameters of the third ventricle and temporal horns, disproportionately enlarged subarachnoid space hydrocephalus, flow void through the aqueduct, focal bulging of the roof of the lateral ventricles, deep white matter hyperintensities, periventricular hyperintensities, and focal widening of sulci and aqueductal stenosis.
RESULTS: In logistic regression models, with shunt outcome as a dependent variable, the ORs for the independent variables, callosal angle, disproportionately enlarged subarachnoid space hydrocephalus, and temporal horns, were significant (P < .05), both in univariate analyses and when adjusted for age, sex, and previous stroke.
CONCLUSIONS: A small callosal angle, wide temporal horns, and occurrence of disproportionately enlarged subarachnoid space hydrocephalus are common in patients with idiopathic normal pressure hydrocephalus and were significant predictors of a positive shunt outcome. These noninvasive and easily assessed radiologic markers could aid in the selection of candidates for shunt surgery.
© 2014 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2014        PMID: 25012669      PMCID: PMC7965311          DOI: 10.3174/ajnr.A4046

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  26 in total

1.  SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME.

Authors:  R D ADAMS; C M FISHER; S HAKIM; R G OJEMANN; W H SWEET
Journal:  N Engl J Med       Date:  1965-07-15       Impact factor: 91.245

2.  Computed tomography of the brain in the diagnosis of and prognosis in normal pressure hydrocephalus.

Authors:  C Wikkelsö; H Andersson; C Blomstrand; M Matousek; P Svendsen
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

3.  Hippocampal atrophy correlates with severe cognitive impairment in elderly patients with suspected normal pressure hydrocephalus.

Authors:  J Golomb; M J de Leon; A E George; A Kluger; A Convit; H Rusinek; S de Santi; A Litt; S H Foo; S H Ferris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

4.  The predictive value of conductance to outflow of CSF in normal pressure hydrocephalus.

Authors:  S E Børgesen; F Gjerris
Journal:  Brain       Date:  1982-03       Impact factor: 13.501

5.  Communicating hydrocephalus in adults: prediction of outcome after ventricular shunting procedures.

Authors:  E C Benzel; A L Pelletier; P G Levy
Journal:  Neurosurgery       Date:  1990-04       Impact factor: 4.654

6.  Is the placement of shunts in patients with idiopathic normal-pressure hydrocephalus worth the risk? Results of a study based on continuous monitoring of intracranial pressure.

Authors:  Maria A Poca; Maria Mataró; Maria Del Mar Matarín; Fuat Arikan; Carmen Junqué; Juan Sahuquillo
Journal:  J Neurosurg       Date:  2004-05       Impact factor: 5.115

7.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

Authors:  P Scheltens; D Leys; F Barkhof; D Huglo; H C Weinstein; P Vermersch; M Kuiper; M Steinling; E C Wolters; J Valk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

8.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

9.  Focal dilation and paradoxical collapse of cortical fissures and sulci in patients with normal-pressure hydrocephalus.

Authors:  A I Holodny; A E George; M J de Leon; J Golomb; A J Kalnin; P R Cooper
Journal:  J Neurosurg       Date:  1998-11       Impact factor: 5.115

Review 10.  Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging.

Authors:  Joanna M Wardlaw; Colin Smith; Martin Dichgans
Journal:  Lancet Neurol       Date:  2013-05       Impact factor: 44.182

View more
  38 in total

1.  High-Convexity Tightness Predicts the Shunt Response in Idiopathic Normal Pressure Hydrocephalus.

Authors:  W Narita; Y Nishio; T Baba; O Iizuka; T Ishihara; M Matsuda; M Iwasaki; T Tominaga; E Mori
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-30       Impact factor: 3.825

Review 2.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

3.  Prognostic value of amyloid PET scan in normal pressure hydrocephalus.

Authors:  Hyemin Jang; Seong Beom Park; Yeshin Kim; Ko Woon Kim; Jung Il Lee; Sung Tae Kim; Kyung Han Lee; Eun-Suk Kang; Yeong Sim Choe; Sang Won Seo; Hee Jin Kim; Yeo Jin Kim; Cindy W Yoon; Duk L Na
Journal:  J Neurol       Date:  2017-11-11       Impact factor: 4.849

Review 4.  Normal pressure hydrocephalus-an overview of pathophysiological mechanisms and diagnostic procedures.

Authors:  Petr Skalický; Arnošt Mládek; Aleš Vlasák; Patricia De Lacy; Vladimír Beneš; Ondřej Bradáč
Journal:  Neurosurg Rev       Date:  2019-11-08       Impact factor: 3.042

5.  Optimal Diagnostic Indices for Idiopathic Normal Pressure Hydrocephalus Based on the 3D Quantitative Volumetric Analysis for the Cerebral Ventricle and Subarachnoid Space.

Authors:  S Yamada; M Ishikawa; K Yamamoto
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-10       Impact factor: 3.825

6.  Absence of Disproportionately Enlarged Subarachnoid Space Hydrocephalus, a Sharp Callosal Angle, or Other Morphologic MRI Markers Should Not Be Used to Exclude Patients with Idiopathic Normal Pressure Hydrocephalus from Shunt Surgery.

Authors:  S Agerskov; M Wallin; P Hellström; D Ziegelitz; C Wikkelsö; M Tullberg
Journal:  AJNR Am J Neuroradiol       Date:  2018-12-06       Impact factor: 3.825

7.  Clinical significance of vitamin D in idiopathic normal pressure hydrocephalus.

Authors:  Chaejin Lee; Hyunwoo Seo; Sang-Youl Yoon; Sung Hyun Chang; Seong-Hyun Park; Jeong-Hyun Hwang; Kyunghun Kang; Chi-Hun Kim; Myong Hun Hahm; Eunhee Park; Jae Yun Ahn; Ki-Su Park
Journal:  Acta Neurochir (Wien)       Date:  2021-04-21       Impact factor: 2.216

8.  Value of MRI-based semi-quantitative structural neuroimaging in predicting the prognosis of patients with idiopathic normal pressure hydrocephalus after shunt surgery.

Authors:  Jiakuan Chen; Wenjie He; Xiejun Zhang; Minrui Lv; Xi Zhou; Xiaolin Yang; Haihua Wei; Haiqin Ma; Hongbing Li; Jun Xia
Journal:  Eur Radiol       Date:  2022-04-30       Impact factor: 5.315

9.  Association between the Onset of Idiopathic Normal Pressure Hydrocephalus Symptoms and Reduced Default Mode Network Connectivity.

Authors:  Koichi Miyazaki; Kohei Hanaoka; Hayato Kaida; Yasutaka Chiba; Kazunari Ishii
Journal:  Dement Geriatr Cogn Disord       Date:  2020-08-19       Impact factor: 2.959

Review 10.  The role of diffusion tensor imaging in idiopathic normal pressure hydrocephalus: A literature review.

Authors:  Irene Grazzini; Duccio Venezia; Gian Luca Cuneo
Journal:  Neuroradiol J       Date:  2020-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.